Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $38.43 --0%
EPS Growth %: -35.0%
Financial Fact:
Engineering and software development: 322.64K
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -35.0%
Financial Fact:
Engineering and software development: 322.64K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- UBS Reiterates Neutral Rating on Scotts Miracle-Gro (SMG) as Cost Pressures to Persist
- Accenture becomes Seattle Seahawks' first global partner
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
